These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27291246)

  • 1. Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions.
    Dhore PW; Dave VS; Saoji SD; Bobde YS; Mack C; Raut NA
    Pharm Dev Technol; 2017 Feb; 22(1):90-102. PubMed ID: 27291246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of plasticizers on manufacturing ritonavir/copovidone solid dispersions via hot-melt extrusion: Preformulation, physicochemical characterization, and pharmacokinetics in rats.
    Zhao Y; Xie X; Zhao Y; Gao Y; Cai C; Zhang Q; Ding Z; Fan Z; Zhang H; Liu M; Han J
    Eur J Pharm Sci; 2019 Jan; 127():60-70. PubMed ID: 30343153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and Evaluation of Phospholipid-Based Complex of Standardized Centella Extract (SCE) for the Enhanced Delivery of Phytoconstituents.
    Saoji SD; Raut NA; Dhore PW; Borkar CD; Popielarczyk M; Dave VS
    AAPS J; 2016 Jan; 18(1):102-14. PubMed ID: 26563253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir.
    Miller DA; Keen JM; Brough C; Ellenberger DJ; Cisneros M; Williams RO; McGinity JW
    J Pharm Pharmacol; 2016 May; 68(5):678-91. PubMed ID: 26454138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellulose derivatives as effective recrystallization inhibitor for ternary ritonavir solid dispersions: In vitro-in vivo evaluation.
    Guan Q; Ma Q; Zhao Y; Jiang X; Zhang H; Liu M; Wang Z; Han J
    Carbohydr Polym; 2021 Dec; 273():118562. PubMed ID: 34560973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir.
    Sinha S; Ali M; Baboota S; Ahuja A; Kumar A; Ali J
    AAPS PharmSciTech; 2010 Jun; 11(2):518-27. PubMed ID: 20238187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of phospholipid as a solubility- and permeability-enhancing excipient for the improved delivery of the bioactive phytoconstituents of Bacopa monnieri.
    Saoji SD; Dave VS; Dhore PW; Bobde YS; Mack C; Gupta D; Raut NA
    Eur J Pharm Sci; 2017 Oct; 108():23-35. PubMed ID: 27590125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Egg White Protein Carrier-Assisted Development of Solid Dispersion for Improved Aqueous Solubility and Permeability of Poorly Water Soluble Hydrochlorothiazide.
    Telange DR; Jain SP; Pethe AM; Kharkar PS
    AAPS PharmSciTech; 2021 Mar; 22(3):94. PubMed ID: 33683493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights.
    Venkateskumar K; Parasuraman S; Gunasunderi R; Sureshkumar K; Nayak MM; Shah SAA; Khoo K; Kai HW
    AAPS PharmSciTech; 2017 Aug; 18(6):2085-2094. PubMed ID: 28004342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS; Elnaggar YS; Abdallah OY
    Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PH-induced nanosegregation of ritonavir to lyotropic liquid crystal of higher solubility than crystalline polymorphs.
    Rodríguez-Spong B; Acciacca A; Fleisher D; Rodríguez-Hornedo N
    Mol Pharm; 2008; 5(6):956-67. PubMed ID: 19434919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Characterization of Pentaerythritol-EudragitRS100 Co-processed Excipients as Solid Dispersion Carriers for Enhanced Aqueous Solubility,
    Telange DR; Bhaktani NM; Hemke AT; Pethe AM; Agrawal SS; Rarokar NR; Jain SP
    ACS Omega; 2023 Jul; 8(28):25195-25208. PubMed ID: 37483203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
    Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
    J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects.
    Onoue S; Nakamura T; Uchida A; Ogawa K; Yuminoki K; Hashimoto N; Hiza A; Tsukaguchi Y; Asakawa T; Kan T; Yamada S
    Eur J Pharm Sci; 2013 Jul; 49(4):453-60. PubMed ID: 23707470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Solid Drug Delivery System Formulation on Poorly Water-Soluble Drug Dissolution and Permeability.
    Krstić M; Popović M; Dobričić V; Ibrić S
    Molecules; 2015 Aug; 20(8):14684-98. PubMed ID: 26287134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.